Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors
Myeloid malignancies such as myelodysplastic syndrome (MDS) & acute myeloid leukemia
(AML) are clonal diseases that emerge and progress due to the expansion of disease …
(AML) are clonal diseases that emerge and progress due to the expansion of disease …
Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors
SR Desai, S Chakraborty… - Best Practice and …, 2023 - einstein.elsevierpure.com
Myeloid malignancies such as myelodysplastic syndrome (MDS) & acute myeloid leukemia
(AML) are clonal diseases that emerge and progress due to the expansion of disease …
(AML) are clonal diseases that emerge and progress due to the expansion of disease …
Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors.
SR Desai, S Chakraborty, A Shastri - Best Practice & research …, 2023 - europepmc.org
Myeloid malignancies such as myelodysplastic syndrome (MDS) & acute myeloid leukemia
(AML) are clonal diseases that emerge and progress due to the expansion of disease …
(AML) are clonal diseases that emerge and progress due to the expansion of disease …
Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors
SR Desai, S Chakraborty… - Best practice & …, 2023 - pubmed.ncbi.nlm.nih.gov
Myeloid malignancies such as myelodysplastic syndrome (MDS) & acute myeloid leukemia
(AML) are clonal diseases that emerge and progress due to the expansion of disease …
(AML) are clonal diseases that emerge and progress due to the expansion of disease …